SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire (RDW) is a top trending stock, with the community actively discussing its short squeeze potential and significant upside in the rapidly expanding space and defense sectors. Strong sentiment is fueled by a reiterated Buy rating and anticipated large-scale government contracts stemming from its Edge Autonomy acquisition, positioning RDW as a key player in the emerging trillion-dollar space economy for 2026 and beyond.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is a hot topic following recent news of new autonomous system orders and a strategic corporate relocation, fueling significant bullish sentiment within the community. Investors are comparing its potential to past high-growth stocks and closely watching its role in the expanding drone and defense sector. Talk centers on anticipated demand from government and critical infrastructure customers for multi-domain security solutions, with many expecting substantial long-term appreciation.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is a focal point of market discussion, driven by its advanced GaN and SiC power solutions which are deemed essential for next-generation AI data centers and align with industry leaders like NVIDIA's 800VDC architecture. The community is actively engaged in intense debate over the stock's substantial short interest and perceived market manipulation, fueling widespread anticipation of a significant short squeeze. Recent strategic partnerships further reinforce Navitas's pivotal role in enabling energy-efficient AI infrastructure, contributing to the strong current interest.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following its announcement of record-breaking December and fourth-quarter vehicle deliveries, positioning the company closer to profitability and its one millionth cumulative vehicle sale. Despite widespread investor optimism surrounding these strong growth figures and its unique battery swap technology, the community is actively discussing frustration over the stock's muted price reaction, largely attributing it to perceived market manipulation.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently trending with strong bullish sentiment following the successful completion of early orbit operations for its BlueBird 6 satellite. The community is buzzing about accelerating plans for direct-to-cell broadband service, including partnerships with major carriers like AT&T expected to begin service in the coming year. Discussions also highlight potential major military contracts, a growing patent portfolio, and a perceived unique market position within the rapidly expanding space and satellite connectivity sector.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as its stock continues to face significant pressure, leading to widespread community frustration and calls for management changes. Despite a strong market, PYPL consistently underperforms, sparking a heated debate between those who see it as a value trap and long-term investors highlighting its low valuation, strong cash flow, and strategic initiatives in the competitive digital payments arena.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending following news that its AI chip unit, Kunlunxin, has filed confidentially for a Hong Kong IPO. This development is driving significant investor optimism and strong buying conviction, as the community discusses its potential to unlock substantial value and solidify Baidu's role in China's AI and semiconductor independence push.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is trending after experiencing a notable price pullback following a significant rally, fueling a divided community discussion. Many are debating whether the dip represents profit-taking or a buying opportunity, given the company's strong mobile advertising platform and AI-driven efficiency. This comes amidst broader conversations around its valuation and past regulatory inquiries in the ad-tech sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly await the outcome of its recent FDA Type B meeting, with community sentiment largely interpreting the ongoing silence as a positive indicator for its lead asset, Sonelokimab. Speculation surrounding a potential acquisition by Merck is also fueling significant discussion, influenced by recent executive share conversions and anticipation for upcoming industry conferences. Despite recent price volatility attributed to market dynamics and tax loss selling, many long-term holders remain confident in the company's core science and future prospects.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to its recent S&P 500 inclusion and significant options activity, with a strong market narrative around insatiable demand for memory and storage in the AI infrastructure boom. The community is actively debating whether its substantial gains reflect a sustained 'memory supercycle' or if a significant valuation pullback is imminent, despite key advancements like BiCS8 technology driving its growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After two years of underperformance, healthcare stocks broadly matched the market in 2025 as investors rotated out of technology. The outlook for 2026 remains mixed, with fundamentals still pressured by patent expirations, Medicare Advantage challenges, and political risks, but several key themes could drive performance. 
Alzheimer’s research is regaining attention, led by Eli Lilly’s Trailblazer-ALZ-3 trial testing whether early intervention can delay disease onset. A positive outcome could reshape treatment strategies and significantly expand the market. UnitedHealth Group is also in focus after its shares collapsed in spring 2025 due to Medicare Advantage problems; management is targeting a return to double-digit growth starting in 2027, though execution will be closely watched. 
Another major theme is the launch of oral GLP-1 weight-loss drugs from Lilly and Novo Nordisk.  
$LLY $BIIB $UNH  $MDT $SPX

StockTwits Web

Lilly(Eli) & Co

Biogen Inc

Unitedhealth Group Inc

Medtronic Plc

S&P 500 Index

After two years of underperformance, healthcare stocks broadly matched the market in 2025 as investors rotated out of technology. The outlook for 2026 remains mixed, with fundamentals still pressured by patent expirations, Medicare Advantage challenges, and political risks, but several key themes could drive performance. 
Alzheimer’s research is regaining attention, led by Eli Lilly’s Trailblazer-ALZ-3 trial testing whether early intervention can delay disease onset. A positive outcome could reshape treatment strategies and significantly expand the market. UnitedHealth Group is also in focus after its shares collapsed in spring 2025 due to Medicare Advantage problems; management is targeting a return to double-digit growth starting in 2027, though execution will be closely watched. 
Another major theme is the launch of oral GLP-1 weight-loss drugs from Lilly and Novo Nordisk.  
